Home › Bloedkankers › Nebraska › Omaha
Bloedkankers klinische studies in Omaha, NE
10 studies voor Bloedkankers zoeken deelnemers op locaties in en rond Omaha (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
RekruterenObservatieonderzoek
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · 9 mijl verwijderd
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
RekruterenFase 1
- The University of Nebraska Medical Center, Omaha
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RekruterenFase 1
- University of Nebraska Medical Center, Omaha
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
RekruterenFase 1
- University of Nebraska Medical Center, Omaha
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruterenObservatieonderzoek
- University of Nebraska Medical Center, Omaha
Halt Aging in Survivors of Blood Cancers
Rekruteren
- University of Nebraska Medical Center, Omaha
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
RekruterenFase 1/2
- Nebraska Cancer Specialists, Omaha
- University of Nebraska Medical Center, Omaha
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RekruterenFase 1/2
- Fred and Pamela Buffett Cancer Center, Omaha
Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation
RekruterenFase 2
- University of Nebraska Medical Center, Omaha
Bloedkankers studies in andere steden
- Houston, TX46 studies
- New York City, NY26 studies
- Boston, MA25 studies
- Washington, DC19 studies
- Baltimore, MD18 studies
- Seattle, WA18 studies
- Los Angeles, CA17 studies
- Durham, NC16 studies
- Chicago, IL15 studies
- Philadelphia, PA14 studies
- Atlanta, GA13 studies
- Nashville, TN13 studies
Andere studies in Omaha
- Prostaatkanker27 studies
- Niet-kleincellige longkanker24 studies
- Borstkanker22 studies
- Colorectale kanker18 studies
- Kanker (alle vormen)18 studies
- Multipel myeloom16 studies
- Non-Hodgkinlymfoom14 studies
- Eierstokkanker14 studies
- Aldermeesklierkanker14 studies
- Plaveiselcelcarcinoom van hoofd en hals13 studies
- Hartfalen13 studies
- Metastatische kanker13 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.